Hearing Aids and Cognitive Health: New Insights from the CHOICE Trial on September 29, 2026 Posted by
The Gift of Time: Revolutionizing Respite Care for the Modern Family Caregiver on September 29, 2026 Posted by
The Silent Crisis: Why We Are Still Medicating Women’s Distress Instead of Understanding It on September 29, 2026 Posted by
Beyond Memory Loss: Addressing the Hidden Crisis of Neuropsychiatric Symptoms in Alzheimer’s Disease on September 29, 2026 Posted by
Beyond the Stigma: Understanding the Vital Role of National Recovery Month in 2026 on September 29, 2026 Posted by
Unlocking the Post-Stroke Enigma: New Research Identifies Micro-Clots as Key to Poor Recovery on September 29, 2026 Posted by
Hearing Aids and Cognitive Health: New Insights from the CHOICE Trial on September 29, 2026 Posted by
The Gift of Time: Revolutionizing Respite Care for the Modern Family Caregiver on September 29, 2026 Posted by
The Silent Crisis: Why We Are Still Medicating Women’s Distress Instead of Understanding It on September 29, 2026 Posted by
Posted in Sleep Health FDA Accepts New Drug Application for AXS-12: A Potential Breakthrough for Narcolepsy-Associated Cataplexy on September 7, 2026
Posted in Medical Innovations The Residency Bottleneck: Examining the Antitrust Challenge to the AAMC’s Medical Application Monopoly on September 1, 2026
Posted in Sleep Health FDA Greenlights Axsome Therapeutics’ Application for Narcolepsy Treatment AXS-12 on August 30, 2026
Posted in Sleep Health FDA Acceptance of AXS-12 New Drug Application Marks Pivotal Milestone for Narcolepsy Patients on August 23, 2026
Posted in Sleep Health FDA Accepts New Drug Application for AXS-12: A Potential Breakthrough for Narcolepsy Patients on August 13, 2026
Posted in Medical Innovations Rethinking UTI Prevention: New Study Validates Simpler, Lower-Dose Estrogen Application for Postmenopausal Women on July 30, 2026
